IL314689A - GPR120 agonists for the treatment of inflammatory bowel diseases - Google Patents

GPR120 agonists for the treatment of inflammatory bowel diseases

Info

Publication number
IL314689A
IL314689A IL314689A IL31468924A IL314689A IL 314689 A IL314689 A IL 314689A IL 314689 A IL314689 A IL 314689A IL 31468924 A IL31468924 A IL 31468924A IL 314689 A IL314689 A IL 314689A
Authority
IL
Israel
Prior art keywords
treatment
inflammatory bowel
bowel disease
gpr120 agonists
gpr120
Prior art date
Application number
IL314689A
Other languages
English (en)
Hebrew (he)
Inventor
Marcello Allegretti
Andrea Aramini
Gianluca Bianchini
Silvia D'alessio
Dutra Rafael Cypriano
Original Assignee
Dompe Farm Spa
Marcello Allegretti
Andrea Aramini
Gianluca Bianchini
Dalessio Silvia
Dutra Rafael Cypriano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa, Marcello Allegretti, Andrea Aramini, Gianluca Bianchini, Dalessio Silvia, Dutra Rafael Cypriano filed Critical Dompe Farm Spa
Publication of IL314689A publication Critical patent/IL314689A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL314689A 2022-03-03 2023-03-03 GPR120 agonists for the treatment of inflammatory bowel diseases IL314689A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22160079.4A EP4238557A1 (en) 2022-03-03 2022-03-03 Gpr120 agonists for the treatment of inflammatory bowel disease
PCT/EP2023/055490 WO2023166203A1 (en) 2022-03-03 2023-03-03 Gpr120 agonists for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
IL314689A true IL314689A (en) 2024-10-01

Family

ID=80628869

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314689A IL314689A (en) 2022-03-03 2023-03-03 GPR120 agonists for the treatment of inflammatory bowel diseases

Country Status (7)

Country Link
US (1) US20250177329A1 (cg-RX-API-DMAC10.html)
EP (2) EP4238557A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025507962A (cg-RX-API-DMAC10.html)
CN (1) CN119031908A (cg-RX-API-DMAC10.html)
CA (1) CA3248186A1 (cg-RX-API-DMAC10.html)
IL (1) IL314689A (cg-RX-API-DMAC10.html)
WO (1) WO2023166203A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120919101A (zh) * 2025-09-26 2025-11-11 南京农业大学 Gw9508在制备治疗轮状病毒的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
CN111317728A (zh) * 2018-12-14 2020-06-23 中国科学院大连化学物理研究所 天然来源ffa4(gpr120)受体激动剂及其应用

Also Published As

Publication number Publication date
EP4486327A1 (en) 2025-01-08
EP4238557A1 (en) 2023-09-06
WO2023166203A1 (en) 2023-09-07
CN119031908A (zh) 2024-11-26
CA3248186A1 (en) 2023-09-07
US20250177329A1 (en) 2025-06-05
JP2025507962A (ja) 2025-03-21

Similar Documents

Publication Publication Date Title
CL2024000183A1 (es) Inhibidores de la proteína tirosina fosfatasa
ZA202101960B (en) Protein tyrosine phosphatase inhibitors
GB201905940D0 (en) 5-aminolevulinic acid for the local treatment of inflammatory bowel disease
EP3986863A4 (en) GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES
MA54544A (fr) Inhibiteurs de la voie jak1 pour le traitement d&#39;une maladie gastro-intestinale
EP3950686A4 (en) N-HETEROAROMATIC AMIDE DERIVATIVES FOR THE TREATMENT OF CANCER
EP3980548A4 (en) COMPOSITIONS FOR THE TREATMENT OF POMPE&#39;S DISEASE
EP3790867A4 (en) KDM1A INHIBITORS FOR DISEASE TREATMENT
EP3603633A4 (en) MEDICAL USE OF ARTEMISIN DERIVATIVES FOR TREATING INFLAMMATABLE COLON DISEASES
EP3986409A4 (en) URIDIN PHOSPHORYLASE (UPASE) INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
EP4298093A4 (en) ANALOGUES FOR THE TREATMENT OF DISEASE
IL319620A (en) New compounds for diagnosing TDP-43 proteinopathies
EP4371573A4 (en) MEDICINAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
HK40115147A (en) Gpr120 agonists for the treatment of inflammatory bowel disease
EP4179298C0 (en) METHOD OF DIAGNOSING INFLAMMATORY INTESTINAL DISEASES
EP4061373A4 (en) METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE
EP3886850A4 (en) VDAC INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
IL327070A (en) Methods for treating cardiovascular diseases
EP4510908A4 (en) SPECTROPOLARIMETRIC IMAGING OF THE EYE FOR THE DIAGNOSIS OF DISEASES
CA3284577A1 (en) Treatment for inflammatory bowel disease
HK40128723A (en) Treatment for inflammatory bowel disease
HUP2100201A1 (hu) Eljárás gyulladásos bélbetegség kockázatának elõrejelzésére
HK40082947A (en) Treatment for the inflammatory bowel disease
EP4519247A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF AN INFLAMMATORY BOWEL DISEASE
AU2020904572A0 (en) Combination therapy for inflammatory bowel disease